JP Morgan Lowers PT On CVS Caremark To $42

JP Morgan has lowered the price target on CVS Caremark Corporation CVS from $45 to $42 and maintains its Overweight rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetAnalyst RatingsConsumer StaplesCVS Caremark CorporationDrug RetailJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!